Cargando…

Waning antibodies in SARS-CoV-2 naïve vaccinees: Results of a three-month interim analysis of ongoing immunogenicity and efficacy surveillance of the mRNA-1273 vaccine in healthcare workers

Detalles Bibliográficos
Autores principales: Tré-Hardy, Marie, Cupaiolo, Roberto, Wilmet, Alain, Beukinga, Ingrid, Blairon, Laurent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The British Infection Association. Published by Elsevier Ltd. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8214908/
https://www.ncbi.nlm.nih.gov/pubmed/34161817
http://dx.doi.org/10.1016/j.jinf.2021.06.017
_version_ 1783710148819156992
author Tré-Hardy, Marie
Cupaiolo, Roberto
Wilmet, Alain
Beukinga, Ingrid
Blairon, Laurent
author_facet Tré-Hardy, Marie
Cupaiolo, Roberto
Wilmet, Alain
Beukinga, Ingrid
Blairon, Laurent
author_sort Tré-Hardy, Marie
collection PubMed
description
format Online
Article
Text
id pubmed-8214908
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The British Infection Association. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-82149082021-06-21 Waning antibodies in SARS-CoV-2 naïve vaccinees: Results of a three-month interim analysis of ongoing immunogenicity and efficacy surveillance of the mRNA-1273 vaccine in healthcare workers Tré-Hardy, Marie Cupaiolo, Roberto Wilmet, Alain Beukinga, Ingrid Blairon, Laurent J Infect Letter to the Editor The British Infection Association. Published by Elsevier Ltd. 2021-09 2021-06-20 /pmc/articles/PMC8214908/ /pubmed/34161817 http://dx.doi.org/10.1016/j.jinf.2021.06.017 Text en © 2021 The British Infection Association. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Tré-Hardy, Marie
Cupaiolo, Roberto
Wilmet, Alain
Beukinga, Ingrid
Blairon, Laurent
Waning antibodies in SARS-CoV-2 naïve vaccinees: Results of a three-month interim analysis of ongoing immunogenicity and efficacy surveillance of the mRNA-1273 vaccine in healthcare workers
title Waning antibodies in SARS-CoV-2 naïve vaccinees: Results of a three-month interim analysis of ongoing immunogenicity and efficacy surveillance of the mRNA-1273 vaccine in healthcare workers
title_full Waning antibodies in SARS-CoV-2 naïve vaccinees: Results of a three-month interim analysis of ongoing immunogenicity and efficacy surveillance of the mRNA-1273 vaccine in healthcare workers
title_fullStr Waning antibodies in SARS-CoV-2 naïve vaccinees: Results of a three-month interim analysis of ongoing immunogenicity and efficacy surveillance of the mRNA-1273 vaccine in healthcare workers
title_full_unstemmed Waning antibodies in SARS-CoV-2 naïve vaccinees: Results of a three-month interim analysis of ongoing immunogenicity and efficacy surveillance of the mRNA-1273 vaccine in healthcare workers
title_short Waning antibodies in SARS-CoV-2 naïve vaccinees: Results of a three-month interim analysis of ongoing immunogenicity and efficacy surveillance of the mRNA-1273 vaccine in healthcare workers
title_sort waning antibodies in sars-cov-2 naïve vaccinees: results of a three-month interim analysis of ongoing immunogenicity and efficacy surveillance of the mrna-1273 vaccine in healthcare workers
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8214908/
https://www.ncbi.nlm.nih.gov/pubmed/34161817
http://dx.doi.org/10.1016/j.jinf.2021.06.017
work_keys_str_mv AT trehardymarie waningantibodiesinsarscov2naivevaccineesresultsofathreemonthinterimanalysisofongoingimmunogenicityandefficacysurveillanceofthemrna1273vaccineinhealthcareworkers
AT cupaioloroberto waningantibodiesinsarscov2naivevaccineesresultsofathreemonthinterimanalysisofongoingimmunogenicityandefficacysurveillanceofthemrna1273vaccineinhealthcareworkers
AT wilmetalain waningantibodiesinsarscov2naivevaccineesresultsofathreemonthinterimanalysisofongoingimmunogenicityandefficacysurveillanceofthemrna1273vaccineinhealthcareworkers
AT beukingaingrid waningantibodiesinsarscov2naivevaccineesresultsofathreemonthinterimanalysisofongoingimmunogenicityandefficacysurveillanceofthemrna1273vaccineinhealthcareworkers
AT blaironlaurent waningantibodiesinsarscov2naivevaccineesresultsofathreemonthinterimanalysisofongoingimmunogenicityandefficacysurveillanceofthemrna1273vaccineinhealthcareworkers